Patent AT-E400286-T1: [Translated] PHARMACEUTICAL PRODUCT CONTAINING AN ANTIPHLOGISTIC ACTIVE INGREDIENT AND LACTALBUMIN HYDROLYZATE AND USE THEREOF

The present invention relates to pharmaceutical compositions based on antiinflammatory active ingredients and to the use thereof for the treatment of rheumatoid diseases. The compositions comprise lactalbumin hydrolysate or a fraction thereof. Substantially lower doses of the antiinflammatory drugs are thus possible than is conventionally necessary to achieve a particular antiinflammatory effect.